Kollbe Ahn

Dr. Ahn is co-founder of ACatechol. Dr. Ahn possesses over 15 years of extensive research experience in adhesives and coatings, enhanced by substantial commercialization experience through strategic partnerships with market leaders in medical device sector. He notably completed a license/acquisition agreement with Danaher/Envista Holdings in 2019 for ACatechol’s non-invasive dental treatment technology. He has held faculty appointments at the University of California, Santa Barbara and the University of Central Florida. Dr. Ahn made a full transition from academia to entrepreneurship during the pandemic in 2020.